775 related articles for article (PubMed ID: 11314800)
1. TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function.
Lu L; Yaszemski MJ; Mikos AG
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S82-91. PubMed ID: 11314800
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles.
Lu L; Stamatas GN; Mikos AG
J Biomed Mater Res; 2000 Jun; 50(3):440-51. PubMed ID: 10737887
[TBL] [Abstract][Full Text] [Related]
3. Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates.
Peter SJ; Lu L; Kim DJ; Stamatas GN; Miller MJ; Yaszemski MJ; Mikos AG
J Biomed Mater Res; 2000 Jun; 50(3):452-62. PubMed ID: 10737888
[TBL] [Abstract][Full Text] [Related]
4. Effects of transforming growth factor beta1 on bonelike tissue formation in three-dimensional cell culture. II: Osteoblastic differentiation.
Lieb E; Vogel T; Milz S; Dauner M; Schulz MB
Tissue Eng; 2004; 10(9-10):1414-25. PubMed ID: 15588401
[TBL] [Abstract][Full Text] [Related]
5. Effects of transforming growth factor beta1 on bonelike tissue formation in three-dimensional cell culture. I. Culture conditions and tissue formation.
Lieb E; Milz S; Vogel T; Hacker M; Dauner M; Schulz MB
Tissue Eng; 2004; 10(9-10):1399-413. PubMed ID: 15588400
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable chitosan scaffolds containing microspheres as carriers for controlled transforming growth factor-beta1 delivery for cartilage tissue engineering.
Cai DZ; Zeng C; Quan DP; Bu LS; Wang K; Lu HD; Li XF
Chin Med J (Engl); 2007 Feb; 120(3):197-203. PubMed ID: 17355821
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment.
Holland TA; Tessmar JK; Tabata Y; Mikos AG
J Control Release; 2004 Jan; 94(1):101-14. PubMed ID: 14684275
[TBL] [Abstract][Full Text] [Related]
9. Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites.
Hedberg EL; Tang A; Crowther RS; Carney DH; Mikos AG
J Control Release; 2002 Dec; 84(3):137-50. PubMed ID: 12468217
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of hyaluronan oligomers from biodegradable polymeric microparticle carriers.
Hedberg EL; Shih CK; Solchaga LA; Caplan AI; Mikos AG
J Control Release; 2004 Nov; 100(2):257-66. PubMed ID: 15544873
[TBL] [Abstract][Full Text] [Related]
11. Controlled release of bioactive TGF-beta 1 from microspheres embedded within biodegradable hydrogels.
DeFail AJ; Chu CR; Izzo N; Marra KG
Biomaterials; 2006 Mar; 27(8):1579-85. PubMed ID: 16140372
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of osteogenesis in vitro and in vivo by a novel osteoblast differentiation promoting compound, TAK-778.
Notoya K; Nagai H; Oda T; Gotoh M; Hoshino T; Muranishi H; Taketomi S; Sohda T; Makino H
J Pharmacol Exp Ther; 1999 Sep; 290(3):1054-64. PubMed ID: 10454478
[TBL] [Abstract][Full Text] [Related]
13. The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres.
Lochmann A; Nitzsche H; von Einem S; Schwarz E; Mäder K
J Control Release; 2010 Oct; 147(1):92-100. PubMed ID: 20603166
[TBL] [Abstract][Full Text] [Related]
14. Interaction of TGF-beta1 and rhBMP-2 on human bone marrow stromal cells cultured in collagen gel matrix.
Kim MK; Niyibizi C
Yonsei Med J; 2001 Jun; 42(3):338-44. PubMed ID: 11456401
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation.
Fromigué O; Marie PJ; Lomri A
J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905
[TBL] [Abstract][Full Text] [Related]
16. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo.
Ruhé PQ; Boerman OC; Russel FG; Spauwen PH; Mikos AG; Jansen JA
J Control Release; 2005 Aug; 106(1-2):162-71. PubMed ID: 15972241
[TBL] [Abstract][Full Text] [Related]
17. Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: osteoconductive biomimetic scaffolds for tissue engineering.
Yang X; Tare RS; Partridge KA; Roach HI; Clarke NM; Howdle SM; Shakesheff KM; Oreffo RO
J Bone Miner Res; 2003 Jan; 18(1):47-57. PubMed ID: 12510805
[TBL] [Abstract][Full Text] [Related]
18. Effects of autogenous growth factors on heterotopic bone formation of osteogenic cells in small animal model.
Arpornmaeklong P; Pripatnanont P; Kittidumkerng W; Mitarnun W
J Craniomaxillofac Surg; 2012 Jun; 40(4):332-40. PubMed ID: 21724408
[TBL] [Abstract][Full Text] [Related]
19. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering.
Holland TA; Tabata Y; Mikos AG
J Control Release; 2005 Jan; 101(1-3):111-25. PubMed ID: 15588898
[TBL] [Abstract][Full Text] [Related]
20. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels.
Holland TA; Tabata Y; Mikos AG
J Control Release; 2003 Sep; 91(3):299-313. PubMed ID: 12932709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
